α-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

α-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. / Skals, Marianne Gerberg; Jørgensen, Niklas R; Leipziger, Jens Georg; Prætorius, Helle.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, 2009, p. 4030-4035.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

Skals, MG, Jørgensen, NR, Leipziger, JG & Prætorius, H 2009, 'α-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis', Proceedings of the National Academy of Sciences of the United States of America, vol. 106, pp. 4030-4035.

APA

Skals, M. G., Jørgensen, N. R., Leipziger, J. G., & Prætorius, H. (2009). α-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. Proceedings of the National Academy of Sciences of the United States of America, 106, 4030-4035.

CBE

Skals MG, Jørgensen NR, Leipziger JG, Prætorius H. 2009. α-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. Proceedings of the National Academy of Sciences of the United States of America. 106:4030-4035.

MLA

Skals, Marianne Gerberg et al. "α-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis". Proceedings of the National Academy of Sciences of the United States of America. 2009, 106. 4030-4035.

Vancouver

Skals MG, Jørgensen NR, Leipziger JG, Prætorius H. α-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. Proceedings of the National Academy of Sciences of the United States of America. 2009;106:4030-4035.

Author

Skals, Marianne Gerberg ; Jørgensen, Niklas R ; Leipziger, Jens Georg ; Prætorius, Helle. / α-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. In: Proceedings of the National Academy of Sciences of the United States of America. 2009 ; Vol. 106. pp. 4030-4035.

Bibtex

@article{17d73930568a11de8dc9000ea68e967b,
title = "α-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis",
abstract = "Escherichia coli is the dominant facultative bacterium in the normal intestinal flora. E. coli is, however, also responsible for the majority of serious extraintestinal infections. There are distinct serotypical differences between facultative and invasive E. coli strains. Invasive strains frequently produce virulence factors such as alpha-hemolysin (HlyA), which causes hemolysis by forming pores in the erythrocyte membrane. The present study reveals that this pore formation triggers purinergic receptor activation to mediate the full hemolytic action. Non-selective ATP-receptor (P2) antagonists (PPADS, suramin) and ATP scavengers (apyrase, hexokinase) concentration dependently inhibited HlyA-induced lysis of equine, murine, and human erythrocytes. The pattern of responsiveness to more selective P2-antagonists implies that both P2X(1) and P2X(7) receptors are involved in HlyA-induced hemolysis in all three species. In addition, our results also propose a role for the pore protein pannexin1 in HlyA-induced hemolysis, as non-selective inhibitors of this channel significantly reduced hemolysis in the three species. In conclusion, activation of P2X receptors and possibly also pannexins augment hemolysis induced by the bacterial toxin, HlyA. These findings potentially have clinical perspectives as P2 antagonists may ameliorate symptoms during sepsis with hemolytic bacteria.",
author = "Skals, {Marianne Gerberg} and J{\o}rgensen, {Niklas R} and Leipziger, {Jens Georg} and Helle Pr{\ae}torius",
year = "2009",
language = "English",
volume = "106",
pages = "4030--4035",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
publisher = "The National Academy of Sciences of the United States of America",

}

RIS

TY - JOUR

T1 - α-hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis

AU - Skals, Marianne Gerberg

AU - Jørgensen, Niklas R

AU - Leipziger, Jens Georg

AU - Prætorius, Helle

PY - 2009

Y1 - 2009

N2 - Escherichia coli is the dominant facultative bacterium in the normal intestinal flora. E. coli is, however, also responsible for the majority of serious extraintestinal infections. There are distinct serotypical differences between facultative and invasive E. coli strains. Invasive strains frequently produce virulence factors such as alpha-hemolysin (HlyA), which causes hemolysis by forming pores in the erythrocyte membrane. The present study reveals that this pore formation triggers purinergic receptor activation to mediate the full hemolytic action. Non-selective ATP-receptor (P2) antagonists (PPADS, suramin) and ATP scavengers (apyrase, hexokinase) concentration dependently inhibited HlyA-induced lysis of equine, murine, and human erythrocytes. The pattern of responsiveness to more selective P2-antagonists implies that both P2X(1) and P2X(7) receptors are involved in HlyA-induced hemolysis in all three species. In addition, our results also propose a role for the pore protein pannexin1 in HlyA-induced hemolysis, as non-selective inhibitors of this channel significantly reduced hemolysis in the three species. In conclusion, activation of P2X receptors and possibly also pannexins augment hemolysis induced by the bacterial toxin, HlyA. These findings potentially have clinical perspectives as P2 antagonists may ameliorate symptoms during sepsis with hemolytic bacteria.

AB - Escherichia coli is the dominant facultative bacterium in the normal intestinal flora. E. coli is, however, also responsible for the majority of serious extraintestinal infections. There are distinct serotypical differences between facultative and invasive E. coli strains. Invasive strains frequently produce virulence factors such as alpha-hemolysin (HlyA), which causes hemolysis by forming pores in the erythrocyte membrane. The present study reveals that this pore formation triggers purinergic receptor activation to mediate the full hemolytic action. Non-selective ATP-receptor (P2) antagonists (PPADS, suramin) and ATP scavengers (apyrase, hexokinase) concentration dependently inhibited HlyA-induced lysis of equine, murine, and human erythrocytes. The pattern of responsiveness to more selective P2-antagonists implies that both P2X(1) and P2X(7) receptors are involved in HlyA-induced hemolysis in all three species. In addition, our results also propose a role for the pore protein pannexin1 in HlyA-induced hemolysis, as non-selective inhibitors of this channel significantly reduced hemolysis in the three species. In conclusion, activation of P2X receptors and possibly also pannexins augment hemolysis induced by the bacterial toxin, HlyA. These findings potentially have clinical perspectives as P2 antagonists may ameliorate symptoms during sepsis with hemolytic bacteria.

M3 - Journal article

VL - 106

SP - 4030

EP - 4035

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

ER -